Literature DB >> 30021808

Recanalization in Cerebral Venous Thrombosis.

Diana Aguiar de Sousa1,2,3, Lia Lucas Neto4,3, Patrícia Canhão1,2,5, José M Ferro1,2,5.   

Abstract

Background and Purpose- The role of recanalization of the occluded dural sinus or vein in the outcome of patients with cerebral venous thrombosis (CVT) is not established. We aimed to systematically review, in patients with CVT, (1) the recanalization rate and its association with (2) clinical outcome and (3) CVT recurrence. Methods- Systematic search in MEDLINE (Medical Literature Analysis and Retrieval System Online), Cochrane Library, and clinicaltrials.gov (inception to September 2017). We considered cohort studies reporting the recanalization rate in adult patients with CVT treated with anticoagulation. Reported rates of venous recanalization at the last follow-up, functional outcome defined using the modified Rankin scale at last follow-up dichotomized for favorable (0-1) and unfavorable (2-6) outcome, and recurrence rate of CVT according to recanalization status were extracted independently by 2 authors. Meta-analyses of proportions were performed using Freeman-Tukey double arcsine transformation. Functional outcomes according to the recanalization status were compared using meta-analysis and ordinal logistic regression. We conducted sensitivity analyses for time to assessment of recanalization and study quality. Results- Four hundred sixty-eight studies were identified, and 19 studies were included. (1) We found report of 694 patients with recanalization in the follow-up among 818 cases of CVT. The overall pooled proportion of patients achieving recanalization was 85% (95% confidence interval, 80-89; I2=58%). In studies with higher methodological quality, the recanalization rate was 77% (95% confidence interval, 70-82; I2=0%). (2) There was a significant increase in the chance of favorable outcome (modified Rankin scale, 0-1) in patients with recanalization with a pooled odds ratio of 3.3 (95% confidence interval, 1.2-8.9; I2=32%) in the random effects meta-analysis and a common odds ratio of 3.3 (95% confidence interval, 1.7-6.3) in the ordinal logistic regression. (3) Data on CVT recurrence according to recanalization was scarce. Conclusions- The overall rate of recanalization in patients receiving anticoagulation was 85%, but exclusion of severe patients from follow-up imaging is a plausible source of bias. Lack of venous recanalization was associated with worse clinical outcome.

Entities:  

Keywords:  adult; follow-up studies; humans; meta-analysis; neuroimaging; prognosis; sinus thrombosis, intracranial

Mesh:

Year:  2018        PMID: 30021808     DOI: 10.1161/STROKEAHA.118.022129

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Stenting of symptomatic lateral sinus thrombosis refractory to mechanical thrombectomy.

Authors:  Guangdong Lu; Jae Ho Shin; Yunsun Song; Deok Hee Lee
Journal:  Interv Neuroradiol       Date:  2019-05-27       Impact factor: 1.610

Review 2.  Cerebral Venous Thrombosis: an Update.

Authors:  José M Ferro; Diana Aguiar de Sousa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-23       Impact factor: 5.081

3.  Recanalisation and Outcome in Cerebral Venous-sinus Thrombosis.

Authors:  D Nagaraja
Journal:  Ann Indian Acad Neurol       Date:  2022-03-01       Impact factor: 1.714

4.  Safety and efficacy comparison between OACs plus single antiplatelet and dual antiplatelet therapy in patients with cerebral venous sinus stenosis poststenting.

Authors:  Chaobo Bai; Zhiying Chen; Xiaoqin Wu; Roxanne Ilagan; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  BMC Neurol       Date:  2022-06-06       Impact factor: 2.903

5.  Chronic intracranial hypertension after cerebral venous and sinus thrombosis - frequency and risk factors.

Authors:  Christina Geisbüsch; Christian Herweh; Christoph Gumbinger; Peter A Ringleb; Markus A Möhlenbruch; Simon Nagel
Journal:  Neurol Res Pract       Date:  2021-05-17

Review 6.  Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

7.  Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Authors:  Gauruv Bose; Justin Graveline; Vignan Yogendrakumar; Risa Shorr; Dean A Fergusson; Gregoire Le Gal; Jonathan Coutinho; Marcelo Mendonça; Miguel Viana-Baptista; Simon Nagel; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

Review 8.  Updates in Cerebral Venous Thrombosis.

Authors:  Arshia Alimohammadi; Diana J Kim; Thalia S Field
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

9.  Safety and efficacy of endovascular thrombectomy in patients with severe cerebral venous thrombosis: A meta-analysis.

Authors:  Gaurav Nepal; Sanjeev Kharel; Riwaj Bhagat; Megan A Coghlan; Jayant K Yadav; Stella Goeschl; Rajan Lamichhane; Subash Phuyal; Rajeev Ojha; Gentle S Shrestha
Journal:  J Cent Nerv Syst Dis       Date:  2022-10-02

10.  Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer.

Authors:  Nadia I Abelhad; Wei Qiao; Naveen Garg; Cristhiam M Rojas-Hernandez
Journal:  Thromb J       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.